Profusa (PFSA) Liabilities and Shareholders Equity (2021 - 2026)

Profusa (PFSA) reported Liabilities and Shareholders Equity of $862000.0 for Q1 2026, down 56.54% on a YoY basis from $2.0 million in Q1 2025, and down 77.17% quarter-over-quarter from $3.8 million in Q4 2025.

Profusa (PFSA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Profusa has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $862000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 56.54% year-over-year to $862000.0; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (down 51.63% YoY), and the FY2025 full-year result was $3.8 million, up 22.84% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $862000.0, down from $3.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $194.7 million in Q4 2022, with the low at $862000.0 in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $50.6 million across 5 years, with a median of $8.8 million in 2024.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity slumped 94.43% — and 2025, when it advanced 22.84%.
  • Profusa's Liabilities and Shareholders Equity stood at $194.7 million in 2022, then plunged by 94.41% to $10.9 million in 2023, then slumped by 71.77% to $3.1 million in 2024, then climbed by 22.84% to $3.8 million in 2025, then sank by 77.17% to $862000.0 in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $862000.0 (Q1 2026), $3.8 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Profusa 1.37 Mn 1.37 Mn - 862,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 862,000.00
Dec 31, 2025 3.78 Mn
Sep 30, 2025 4.25 Mn
Jun 30, 2025 1.96 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 3.07 Mn
Sep 30, 2024 8.78 Mn
Jun 30, 2024 8.59 Mn
Mar 31, 2024 8.50 Mn
Dec 31, 2023 10.88 Mn
Sep 30, 2023 10.80 Mn
Jun 30, 2023 10.90 Mn
Mar 31, 2023 10.74 Mn
Dec 31, 2022 194.74 Mn
Sep 30, 2022 193.79 Mn
Jun 30, 2022 192.86 Mn
Mar 31, 2022 192.87 Mn
Dec 31, 2021 193.06 Mn